Written in
Featured research from recent issues of Blood
PAPER SPOTLIGHT
A Surprising
Conclusion: HighCost Blood Cancer
Treatments May Be
Cost-Effective
Although the past 15 years have seen great progress
in the treatment of hematologic malignancies, F